Bloomberg News 9/09/2020
Quote
U.S. National Institutes of Health Director Francis Collins told a Senate committee Wednesday that AstraZeneca Plc’s closely watched Covid-19 vaccine trial had been halted due to a “spinal cord problem.” ...
...Appearing before the Senate Committee on Health, Education, Labor & Pensions, Collins said that the severe adverse event in question was transverse myelitis, a neurological disorder that causes inflammation of the spinal cord. If AstraZeneca’s review finds the adverse event is related to the vaccine, all the doses already manufactured will be thrown away, Collins said....
c
sirI, MSN, APRN, NP
17 Articles; 45,877 Posts
A COVID-19 vaccine trial participant contracted an inflammatory syndrome that affects the spinal cord. Unsure how it is linked to AstraZeneca’s vaccine.
Drugmaker Pauses Covid-19 Vaccine Trial for Safety Review